Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients
This clinical trial update analyzes discontinuation rates, adherence patterns, hospitalizations, and costs associated with oral anticoagulan…
-
FDA approval · 2016-06-06FDA Approved: DOFETILIDE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved Dr. Reddy's Laboratories' original application for dofetilide, enabling a generic version of the antiarrhythmic. It is indicate…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Singapore Atrial Fibrillation Study
Clinical trial update for a Singapore atrial fibrillation study (NCT02791022) with no status details disclosed in the snippet.
-
FDA approval · 2016-05-29FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited.
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Predictors of Anticoagulation Control on Warfarin Therapy
A completed clinical trial update examining predictors of maintaining therapeutic anticoagulation with warfarin in patients with atrial fibr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden
This completed trial update compares adherence to apixaban and warfarin among atrial fibrillation patients in Sweden, highlighting real-worl…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation [Phase 3]
Phase 3 clinical trial evaluating whether aldosterone inhibition reduces myocardial diffuse fibrosis to prevent recurrent atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Improving DEtection of Atrial fibriLlation in Primary Care With the MyDiagnostick [Phase 3]
A Phase 3 clinical trial update reports completion of a study evaluating the MyDiagnostick device for improving detection of atrial fibrilla…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Screening for Silent Atrial Fibrillation During Influenza Vaccination [NA]
This trial examined screening for silent atrial fibrillation in the context of influenza vaccination and is listed as completed.
-
FDA approval · 2016-05-11FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for propafenone hydrochloride (generic) manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
This clinical trial update reports replication data on 30-day readmission rates among nonvalvular atrial fibrillation patients treated with …
-
FDA approval · 2016-05-10FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
The FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) filed by Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Genotype-Guided Warfarin Therapy Trial [NA]
This document provides an update on a completed clinical trial evaluating genotype-guided dosing of warfarin across patients with atrial fib…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation [Phase 4]
Phase 4 clinical trial comparing pulmonary vein isolation with continued antiarrhythmic drug therapy versus stopping antiarrhythmic drugs in…
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Clarification of Optimal Anticoagulation Through Genetics [Phase 3]
A Phase 3 trial evaluating genotype-guided warfarin dosing to optimize anticoagulation has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: CopenHeartRFA - Integrated Rehabilitation of Patients Treated for Atrial Fibrillation With Radio Frequency Ablation [NA]
This clinical trial evaluated integrated rehabilitation for patients with atrial fibrillation who were treated with radiofrequency ablation,…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation [Phase 3]
Phase 3 clinical trial update comparing continuous versus intermittent heparin infusion during catheter ablation of atrial fibrillation. The…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial) [Phase 3]
Phase 3 clinical trial evaluating the effect of adenosine on the persistent pulmonary vein isolation line in atrial fibrillation; results ha…
-
FDA label_change · 2016-04-08FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
FDA approved a supplemental application for verapamil hydrochloride, resulting in changes to its labeling.
-
FDA approval · 2016-04-07FDA Approved: ESMOLOL HYDROCHLORIDE IN WATER — Original Application (WG Critical Care, LLC)
FDA approved Esmolol hydrochloride in water as a new drug product under NDA205703 (Original Application) from WG Critical Care, LLC.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation [NA]
A Medtronic BRC-sponsored trial evaluating spinal cord stimulation to treat post-operative atrial fibrillation has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist [Phase 2]
Phase 2 trial results update on reinitiating anticoagulation after temporary withdrawal of a vitamin K antagonist in patients with atrial fi…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa
This clinical trial update reports on management strategies for major bleeding events in atrial fibrillation patients taking Pradaxa (dabiga…
-
CLINICAL_TRIALS other · 2016-03-29Clinical Trial Update: Magnesium Sulphate for Treatment of New Onset Atrial Fibrillation in Medical Intensive Care Unit Patient [NA]
A Mahidol University trial investigates magnesium sulfate for treating new-onset atrial fibrillation in ICU patients; status is currently un…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) [Phase 3]
AFFIRM Phase 3 trial on rhythm management in atrial fibrillation has completed.